Mykola Iabluchanskyi

Frailty in gerontology has a surprisingly recent history as a formal concept. For most of the twentieth century, clinicians recognized “frail” older patients, but lacked a precise language or tools to describe what they were seeing.  Early observations without a framework In everyday practice, many older people were described as “weak,” “frail,” or “run down,” but these were intuitive labels rather than defined clinical states. A chart could list dozens of diagnoses and largely “normal” lab values, yet the global impression remained: this patient “takes a hit” much worse than others of similar age and disease burden. There were almost no instruments to formalize this difference in reserve or vulnerability.  Twentieth‑century biomedicine focused on acute, organ‑specific disease: one disease, one organ, one lesion. Within that frame, an older adult with multiple chronic conditions and slow recovery was coded simply as an “elderly patient,” not as someone with a distinct syndrom...

  The Promise That Expired For more than a century, school and university life rested on a single linear contract: endure years of preparation now, and real life will begin afterward. Study hard, collect the right certificates, wait for the stamp of authority — then the doors will open. Learning was a queue, and the queue was the point. That contract has expired. In 2026, the world outside the classroom is moving faster than the syllabi inside it. Professions once considered stable are being rewritten in real time by AI systems. The idea of " front-loading " twenty years of education and drawing on static capital for the next forty is collapsing under the weight of its own assumptions. Students who step out of the waiting room no longer find a stable corridor — they find a high-speed moving train.  Their real deficit is not access to information. It is the sovereignty of judgment : the ability to decide what matters, what to trust, and what to do next, without outsourcing the...

 For decades, mental health has been measured in symptoms. We count panic attacks, chart the depth of low moods, and catalogue sleep disturbances as if a patient were a machine to be audited rather than a navigator trying to find their way through a storm. But if we shift our clinical perspective — from passive bearer of diagnoses to active participant in life — a different and more honest measure of wellbeing emerges: the quality of the decisions a patient is able to make every day . From Symptoms to Functional Capacity In the theory of functional systems , a decision is never a simple act of will. It is the final result of a complex neurobiological and social network striving toward a useful outcome. From this vantage point, the quality of a patient's choices is not a verdict on their strength of character. It is a mirror of the environment in which that choosing happens. When we document that a patient is depressed, we describe a static state. When we ask  why their decisio...

  Breathing is sustained without volitional input. Throughout sleep, periods of inattention, and systemic illness, brainstem respiratory networks maintain rhythmic drive to the respiratory musculature independent of conscious participation. In its automaticity, respiration resembles cardiac function — a vital cycle generated and regulated below the threshold of deliberate control. Respiration diverges from cardiac function, however, in one physiologically significant way: it is accessible to voluntary modulation . An individual can elect to pause before phonation, prolong exhalation to attenuate arousal, or alter respiratory rate in response to situational demands. This capacity for deliberate intervention reflects a structural feature of the nervous system — the convergence of automatic and voluntary control pathways within a single motor output — and has direct implications for the clinical application of breathing-based interventions. Automatic Respiratory Regulation Under base...

We have spent a century obsessed with a single number. How long did they live? Ninety-two. Eighty-seven. A hundred and one. We announce it in obituaries, track it in demographic reports, and celebrate it as proof of medical progress. But that number — lifespan — tells us almost nothing about the life it claims to measure. Two people can share the same lifespan and inhabit completely different existences. One crosses the finish line still recognizably themselves. The other stopped being present years before the body gave out. To talk honestly about aging, we need three coordinates, not one. Lifespan, healthspan , and wellspan — each asks a different question, and together they form the only framework that takes the whole person seriously. Lifespan Is Just the Clock Lifespan is time in its most stripped-down form: the interval between first breath and last. It is useful for statisticians, actuaries, and headline writers. It is far less useful for anyone trying to understand how a human...

There is a persistent fantasy in the history of thinking about intelligence: that mind is essentially weightless. That it is a pure process — reasoning, pattern recognition, information integration — that could, in principle, run on any substrate, in any form, detached from the particular physical circumstances of its operation. The history of cognitive science and artificial intelligence is partly the history of this fantasy, and of its repeated failure. The failure is not technical. It is conceptual. Mind, on the best available evidence from neuroscience , phenomenology , and biology, is not something that happens to be housed in a body. It is something a body does. Consciousness — understood as the combination of inner experience and reflection on that experience — is rooted, at its origin, in a vulnerable, metabolically regulated organism that depends on its environment to survive, that can be harmed, that is always at some level at risk. This is not a romantic claim about the s...

A medication prescribed at the right dose but the wrong frequency is not the right medication. This is a principle that pharmacology has understood in theory for decades and that clinical practice has been slow to absorb. The standard instruction — take once daily — reflects the average patient, a statistical construct that describes no one in particular. The actual patient sitting across from the clinician metabolizes drugs quickly, slowly, or somewhere in between, and that difference determines not only how well a treatment works but whether it causes harm. Most antihypertensive drugs are designed with a twenty-four-hour action profile in mind. The once-daily recommendation assumes that the drug will remain at therapeutically effective concentrations throughout that period, then be cleared and replaced by the next dose. For a patient with ordinary metabolic rate, this assumption is reasonable. For patients at either end of the metabolic spectrum, it is often wrong in ways that are ...